Quick verdict
Short answer: ZoomInfo is the incumbent for large US revenue teams. XLEAD is the self-serve alternative for SMB and mid-market teams that prioritize exportable lists and predictable monthly cost.
| XLEAD | ZoomInfo | |
|---|---|---|
| Buyer motion | Self-serve checkout | Sales-led custom contracts |
| Pricing | €49 / €79 / €119 per month (published) | Quote on zoominfo.com/pricing |
| Data sourcing | AI research on public sources | ML on public web + partners + in-house research |
| Primary strength | List build, verify, Excel export, 180 countries | Enterprise US depth, intent, integrations |
| Contributory inbox pool | No | Different model (public profiles + partners; see ZoomInfo docs) |
| Best for | Lean global outbound teams | Enterprise GTM with dedicated ops |
Where ZoomInfo is genuinely strong
ZoomInfo is not popular by accident:
- Scale of automated collection. ZoomInfo states its ML reviews public information across millions of sites and domains daily, including corporate sites, press releases, SEC filings, and job posts.
- Human research layer. Its FAQ describes an in-house team that verifies algorithm output and expands contact, funding, and event data.
- Enterprise feature set. Intent, technographics, org charts, and integrations matter when you run coordinated marketing and sales at scale.
- Privacy operations. ZoomInfo documents GDPR/CCPA alignment on its data sources page and offers profile control via the Trust Center.
If your CFO already line-items six-figure data spend and your ops team owns Salesforce hygiene, ZoomInfo is in the conversation for a reason.
Where XLEAD is different
XLEAD does not try to replace a full enterprise RevOps stack. It solves a narrower problem well:
- Self-serve start. Pick a plan on xlead.app/pricing without a procurement cycle.
- Monthly enrichment quotas, not opaque credits. 500 / 1,000 / 1,500 enriched leads per month by tier, plus Golden AI enrichments and user seats documented in product pricing.
- Excel and CSV export as default workflow. Built for teams that move lists into CRM or outreach tools you already pay for.
- Public-source provenance. AI research agents on public sources; no contributory inbox network like Apollo's documented model.
Related reads: XLEAD vs Apollo, Best Apollo alternatives in 2026.
How each one sources its data
Short answer: ZoomInfo aggregates public web signals, partner feeds, and manual research into "Public Profiles." XLEAD researches public sources with AI agents and verifies contacts before you export.
ZoomInfo explains on How does ZoomInfo get my information? that profiles combine automated collection from public business sources with third-party partners and internal research. Its data sources page adds that it does not track personal browsing history or process individuals solely in a personal capacity.
XLEAD finds companies and decision-makers from public sources, verifies contact channels, and does not harvest user inboxes into a shared database.
Buyer implication: Both vendors publish sourcing narratives. ZoomInfo optimizes for breadth and enterprise compliance operations; XLEAD optimizes for transparent public research and fast export for smaller teams.
Pricing and buying motion
ZoomInfo: Custom pricing via sales (pricing page). Budget for annual contracts, onboarding, and possible add-ons. This is not comparable to a €49 self-serve checkout.
XLEAD:
| Plan | €/mo | Enriched leads/mo | Users |
|---|---|---|---|
| Essential | 49 | 500 | 2 |
| Professional | 79 | 1,000 | 3 |
| Scale | 119 | 1,500 | 5 |
Practical takeaway: Compare total cost of ownership. ZoomInfo wins on enterprise depth when you will use intent, integrations, and admin features. XLEAD wins when you need lists exported this week under a known monthly cap.
Which should you choose?
- Choose ZoomInfo if you are US-enterprise focused, need intent and advanced GTM data, and have budget plus ops to implement it.
- Choose XLEAD if you are a lean team selling globally, want flat monthly quotas, and prioritize Excel-ready decision-maker lists from public-source research.